Article
Adeno-associated virus gene therapy prevents progression of kidney disease in genetic models of nephrotic syndrome
9 Aug 2023
Abstract excerpt
Gene therapy for kidney diseases has proven challenging. Adeno-associated virus (AAV) is used as a vector for gene therapy targeting other organs, with particular success demonstrated in monogenic diseases. We aimed to establish gene therapy for the kidney by targeting a monogenic disease of the kidney podocyte. The most common cause of childhood genetic nephrotic syndrome is mutations in the podocyte gene NPHS2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
